These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17042060)

  • 1. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.
    Velenik V; Anderluh F; Oblak I; Strojan P; Zakotnik B
    Croat Med J; 2006 Oct; 47(5):693-700. PubMed ID: 17042060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.
    Kim JS; Kim JS; Cho MJ; Song KS; Yoon WH
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):403-8. PubMed ID: 12243814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.
    Kim JC; Kim TW; Kim JH; Yu CS; Kim HC; Chang HM; Ryu MH; Park JH; Ahn SD; Lee SW; Shin SS; Kim JS; Choi EK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):346-53. PubMed ID: 15913913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.
    Marsh Rde W; George TJ; Siddiqui T; Mendenhall WM; Zlotecki RA; Grobmyer S; Hochwald S; Chang M; Larson B; King J
    Am J Clin Oncol; 2010 Jun; 33(3):251-6. PubMed ID: 19823074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
    Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
    Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
    Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
    Velenik V; Ocvirk J; Oblak I; Anderluh F
    Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.
    Velenik V; Oblak I; Anderluh F
    Radiat Oncol; 2010 Sep; 5():88. PubMed ID: 20920276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.
    Elwanis MA; Maximous DW; Elsayed MI; Mikhail NN
    World J Surg Oncol; 2009 Jun; 7():52. PubMed ID: 19508705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY; Jung KH; Kim TH; Kim DW; Chang HJ; Jeong JY; Kim YH; Son SH; Yun T; Hong CW; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):378-84. PubMed ID: 17097835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.
    Korkolis DP; Boskos CS; Plataniotis GD; Gontikakis E; Karaitianos IJ; Avgerinos K; Katopodi A; Xinopoulos D; Dimitroulopoulos D; Beroukas K; Vassilopoulos PP
    Anticancer Res; 2007; 27(1B):541-5. PubMed ID: 17348439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer.
    Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR
    Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.
    Velenik V; Ocvirk J; Music M; Bracko M; Anderluh F; Oblak I; Edhemovic I; Brecelj E; Kropivnik M; Omejc M
    Radiat Oncol; 2011 Aug; 6():105. PubMed ID: 21880132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.
    De Paoli A; Chiara S; Luppi G; Friso ML; Beretta GD; Del Prete S; Pasetto L; Santantonio M; Sarti E; Mantello G; Innocente R; Frustaci S; Corvò R; Rosso R
    Ann Oncol; 2006 Feb; 17(2):246-51. PubMed ID: 16282246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
    Desai SP; El-Rayes BF; Ben-Josef E; Greenson JK; Knol JA; Huang EH; Griffith KA; Philip PA; McGinn CJ; Zalupski MM
    Am J Clin Oncol; 2007 Aug; 30(4):340-5. PubMed ID: 17762432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
    Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer.
    de las Heras M; Arias F; del Moral-Avila R; Gómez-Millán J; Jiménez E; Wals A; Tisaire JL; Alcantara MP
    Clin Transl Oncol; 2013 Apr; 15(4):294-9. PubMed ID: 22855196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.